Magenta Therapeutics, Inc. Collaboration Agreements
8 Contracts & Agreements
- Amendment #1 to Collaboration Agreement, effective as of December 31, 2020, pursuant to the Collaboration Agreement by and between the Registrant and National Marrow Donor Program... (Filed With SEC on March 3, 2021)
- Amendment #3 to Project Rider #1, effective as of December 16, 2020, pursuant to the Collaboration Agreement by and between the Registrant and National Marrow Donor Program d/b/a... (Filed With SEC on March 3, 2021)
- Amendment #2 to Project Rider #1, effective as of November 13, 2019, pursuant to the Collaboration Agreement by and between the Registrant and National Marrow Donor Program d/b/a... (Filed With SEC on March 3, 2021)
- Amendment #1 to Project Rider #3, effective as of August 26, 2019, pursuant to the Collaboration Agreement by and between the Registrant and National Marrow Donor Program d/b/a Be... (Filed With SEC on November 13, 2019)
- Amendment #1 to Project Rider #1, effective as of December 6, 2018, pursuant to the Collaboration Agreement by and between the Registrant and Be The Match BioTherapies, dated as... (Filed With SEC on March 19, 2019)
- Project Rider #3, effective as of September 6, 2018, pursuant to the Collaboration Agreement by and between the Registrant and Be The Match BioTherapies, dated as of November 10,... (Filed With SEC on March 19, 2019)
- Project Rider #2, effective as of June 26, 2018, pursuant to the Collaboration Agreement by and between the Registrant and Be The Match BioTherapies, dated as of November 10, 2017 (Filed With SEC on March 19, 2019)
- Collaboration Agreement by and between Be The Match BioTherapies and the Registrant, dated as of November 10, 2017 (Filed With SEC on May 24, 2018)
